Emergent BioSolutions Inc. Common Stock (NY:EBS)

6.330 -0.040 (-0.63%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

19 20 Next >

Recap: Emergent BioSolutions Q1 Earnings ↗

May 09, 2023

Via Benzinga

Emergent BioSolutions Reports Financial Results For First Quarter 2023

May 09, 2023

From Emergent BioSolutions

Via GlobeNewswire

Emergent Plans $50 Price Point For Narcan OTC Version For Opioid Overdose Reversal ↗

April 21, 2023

Emergent BioSolutions Inc (NYSE: EBS) looks to price its over-the-counter (OTC) version of its opioid overdose reversal Narcan at around $50 per carton of two 4 mg doses.

Via Benzinga

Emergent BioSolutions to Release First Quarter 2023 Financial Results and Conduct Conference Call on May 9, 2023

April 19, 2023

From Emergent BioSolutions

Via GlobeNewswire

Why Emergent BioSolutions Stock Is Soaring Today ↗

March 30, 2023

Emergent received a key approval from the FDA, but just how good is this news?

Via The Motley Fool

FDA Approves First OTC Naloxone Nasal Spray For Opioid Overdose ↗

March 29, 2023

Via Benzinga

Why Emergent BioSolutions Stock Is Sinking Today ↗

March 17, 2023

Investors reacted negatively to an analyst's downgrade of the healthcare stock.

Via The Motley Fool

CPI Sent Market Surging - But Some Stocks Took A Hit: Spotlight On Top Gainers And Hard-Hit Decliners ↗

April 12, 2023

The market is trading higher on Wednesday after the Labor Department reported the latest Consumer Price Index figure for the month of March. While most stocks are trading higher alongside the major...

Via Benzinga

Tesla, Apple, Riot Platforms, AMC, Emergent Biosolutions: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

April 10, 2023

U.S.

Via Benzinga

Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move ↗

April 10, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 10, 2023 ↗

April 10, 2023

Via Benzinga

Micron Technology, Greenbrier Companies And Other Big Stocks Moving Higher On Monday ↗

April 10, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling over 100 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 30, 2023

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...

Via Benzinga

Sprinklr, EVgo, Emergent BioSolutions And Other Big Stocks Moving Higher On Thursday ↗

March 30, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Emergent Biosciences (EBS) Stock Pops as FDA Approves Over-the-Counter Narcan ↗

March 29, 2023

EBS stock is on the move as Emergent Biosciences expects its opioid emergency drug to be available soon without a prescription.

Via InvestorPlace

FDA Approves Over The Counter Sale Of Opioid Reversal Drug Narcan ↗

March 29, 2023

Narcan, the prescription nasal spray that reverses opioid overdoses can now be sold over the counter (OTC), said the FDA on Wednesday, reported the NY Times, thereby authorizing a move that has...

Via Benzinga

U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment

March 29, 2023

From Emergent BioSolutions

Via GlobeNewswire

Why Emergent Biosolutions Stock Is Surging Today ↗

March 29, 2023

Emergent Biosolutions Inc (NYSE: EBS) shares are trading higher Wednesday following reports the U.S. Food and Drug Administration approved the company's Naloxone nasal spray for over-the-counter use.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 29, 2023

Via Benzinga

Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket ↗

March 29, 2023

Gainers LogicMark, Inc. (NASDAQ: LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022.

Via Benzinga

Cal-Maine Foods, Lululemon Athletica And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

March 29, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 17, 2023

Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.

Via Benzinga

First Republic Bank, Blend Labs, Purple Innovation And Other Big Stocks Moving Lower On Friday ↗

March 17, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023 ↗

March 17, 2023

Via Benzinga

Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

March 09, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 09, 2023

It's time for another breakdown of the biggest pre-market stock movers traders will want to know about on Thursday morning!

Via InvestorPlace

Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional' ↗

March 01, 2023

Novavax Inc (NASDAQ: NVAX) shares are crashing Wednesday after the company warned that substantial doubt exists regarding its ability to continue. Jim Cramer isn't surprised.

Via Benzinga

Why Emergent BioSolutions Stock Tumbled by Almost 12% Today ↗

February 28, 2023

It's not a good day for investors when their company reports a shocking plunge into the red.

Via The Motley Fool

Emergent BioSolutions (EBS) Q4 2022 Earnings Call Transcript ↗

February 27, 2023

EBS earnings call for the period ending December 31, 2022.

Via The Motley Fool

Emergent BioSolutions Reports Financial Results for Fourth Quarter 2022

February 27, 2023

From Emergent BioSolutions

Via GlobeNewswire

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.